greeksoup/ stock research

National Health Investors (NHI) FY2022 results: revenue $278 million, down 6.9% on the year

National Health Investors Inc. (NHI) reported revenue of $278 million for fiscal 2022, the year ended 31 December 2022, down 6.9% on the year before. Net income was $66 million, down 40.6%, and diluted earnings per share $1.48. The figures are the company's own, from the 10-K it filed with the SEC on 21 February 2023.

Revenue
$278 million
-6.9% on the year
FY2015FY2022
Operating margin
n/a
FY2015FY2022
Net income
$66 million
-40.6% on the year
FY2015FY2022
Diluted EPS
$1.48
-39.3% on the year
FY2015FY2022

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2022 · Q2 FY2022 · Q3 FY2022 · Q4 FY2022

Income statement (profit and loss)

$ millionFY2022FY2021FY2020On the yearLast 8 years
Revenue278299333-6.9%
Interest expense44.950.852.9-11.6%
Net income66.4112185-40.6%
Net margin23.9%37.4%55.6%
Diluted EPS$1.48$2.44$4.14-39.3%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2022FY2021FY2020On the yearLast 8 years
Operating cash flow185211232-12.1%
Capital expenditure11.050.3117-78.2%
Free cash flow174161115+8.6%
Free cash flow margin62.7%53.7%34.7%
Cash from investing198185-89.7+6.8%
Cash from financing-401-403-112
Share-based compensation8.65.15.4+69.4%
Buybacks1520.00.0
Dividends paid162183195-11.6%
Dividend per share$3.60$3.80$4.41-5.3%
Diluted shares, weighted45m46m45m-2.0%
Shares outstanding at period end43m46m45m-5.4%

Balance sheet

$ millionFY2022FY2021FY2020On the yearLast 8 years
Shareholders' equity1,2701,5071,512-15.7%
Non-controlling interest9.99.910.7-0.4%
Redeemable equity9.80.0n/a
Debt1,1481,2431,499-7.7%
Other liabilities70.079.098.3-11.4%
Total liabilities and equity2,5072,8393,120-11.7%
Fixed assets2,1182,3182,667-8.6%
Loans233300292-22.3%
Cash and equivalents19.337.443.3-48.4%
Receivables3.63.22.6+12.8%
Other assets133180115-26.2%
Total assets2,5072,8393,120-11.7%

10-K for the year ended 31 December 2022, filed 21 February 2023: the filing.